Integral Health Asset Management, LLC Biogen Inc. Transaction History

Integral Health Asset Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$256.56 - $292.34 $10.3 Million - $11.7 Million	40,000 New	40,000 $11.1 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $9.73 Million - $13.4 Million	50,000 New	50,000 $13.4 Million
Q2 2022 Aug 03, 2022	SELL	$187.54 - $223.02 $2.81 Million - $3.35 Million	-15,000 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $3.88 Million - $4.88 Million	-20,000 Reduced 57.14%	15,000 $3.16 Million
Q4 2021 Feb 02, 2022	BUY	$223.92 - $287.77 $7.84 Million - $10.1 Million	35,000 New	35,000 $8.4 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $9.9 Million - $12.9 Million	-35,000 Closed	0 $0
Q2 2021 Aug 30, 2021	SELL	$259.0 - $414.71 $9.07 Million - $14.5 Million	-35,000 Reduced 50.0%	35,000 $12.1 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $18.1 Million - $29 Million	70,000 New	70,000 $24.2 Million
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $2.43 Million - $2.85 Million	-10,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $2.36 Million - $3.56 Million	10,000 New	10,000 $2.45 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.